Reference intervals for blood androgen levels in women of early and late reproductive age


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Objective. To form reference intervals for blood androgen levels in women depending on their age. Materials and methods. The study included 1140 women who were divided into two groups depending on their age: late reproductive age (LR A) group consisting of women aged 35 years or older and early reproductive age (ERA) group which included patients under 35 years. To determine a number of hormones, patients of LRA group were divided into two subgroups: women of middle reproductive age (35-39 years) and women of late reproductive age (40-49 years). There was an assessment of the level of the following androgens: total testosterone (TT), free testosterone (FT), dehydroepiandrosterone sulfate (DHEAS), dihydrotestosterone (DHT), and rostenedione (A) and sex hormone-binding globulin (SHBG). The calculation of 2.5 and 97.5 percentiles for these indicators was done according to the recommendations of the International Federation of Clinical Chemistry (IFCC) using statistical processing of reference values. Results. Reference intervals were obtained for TT, FT, DHT, DHEAS, A and SHBG in reproductive-aged women and significant differences were revealed in the indicators of LRA and ERA women (p<0.05). Conclusion. During the assessment of androgen levels in women, it is necessary to evaluate not only the upper reference value, as its excess indicates hyperandrogenism, but also the lower reference value, which can be indicative of androgen deficiency. It is also important to stratify patients correctly into groups depending on their age. The obtained data can be used in other clinical and diagnostic laboratories after the appropriate validation, according to the requirements of the Clinical and Laboratory Standards Institute (CLSI).

Texto integral

Acesso é fechado

Sobre autores

Alla Gavisova

Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: gavialla@yandex.ru
Ph.D., Senior Researcher of the 1st Gynecology Department Moscow, Russia

Tatyana Ivanets

Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: т_ivanets@oparina4.ru
Dr. Med. Sci., Head of the Clinical Diagnostic Laboratory Moscow, Russia

Nataliya Dolgushina

Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Dr. Med. Sci., Professor, Deputy Director - Head of the Department of Research Administration Moscow, Russia

Bibliografia

  1. Bachmann G., Bancroft J., Braunstein G., Burger H., Davis S., Dennerstein L. et al. Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil. Steril. 2002; 77(4): 660-5. https://dx.doi.org/10.1016/s0015-0282(02)02969-2.
  2. Burger H.G. Androgen production in women. Fertil. Steril. 2002; 77(Suppl. 4): S3-5. https://dx.doi.org/10.1016/s0015-0282(02)02985-0.
  3. Simpson E.R. Aromatization of androgens in women: current concepts and findings. Fertil. Steril. 2002; 77(Suppl. 4): S6-10. https://dx.doi.org/10.1016/s0015-0282(02)02984-9.
  4. Abraham G.E. Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. J. Clin. Endocrinol. Metab. 1974; 39(2): 340-6. https://dx.doi.org/10.1210/jcem-39-2-340.
  5. Longcope C. Adrenal and gonadal androgen secretion in normal females. Clin. Endocrinol. Metab. 1986; 15(2): 213-28. https://dx.doi.org/10.1016/s0300-595x(86)80021-4.
  6. Luu-The V., Dufort I., Pelletier G., Labrie F. Type 5 17beta-hydroxysteroid dehydrogenase: its role in the formation of androgens in women. Mol. Cell. Endocrinol. 2001; 171(1-2): 77-82. https://dx.doi.org/10.1016/s0303-7207(00)00425-1.
  7. Labrie F., Diamond P., Cusan L., Gomez J.L., Belanger A., Candas B. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J. Clin. Endocrinol. Metab. 1997; 82(10): 3498-505. https://dx.doi.org/10.1210/jcem.82.10.4306.
  8. Walters K.A., Handelsman D.J. Role of androgens in the ovary. Mol. Cell. Endocrinol. 2018; 465: 36-47. https://dx.doi.org/10.1016/j.mce.2017.06.026.
  9. Montoya-Botero P., Rodriguez-Purata J., Polyzos N.P Androgen supplementation in assisted reproduction: where are we in 2019? Curr. Opin. Obstet. Gynecol. 2019; 31(3): 188-94. https://dx.doi.org/10.1097/GCO.0000000000000532.
  10. Vendola K., Zhou J., Wang J., Famuyiwa O.A., Bievre M., Bondy C.A. Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. Biol. Reprod. 1999; 61(2): 353-7. https://dx.doi.org/10.1095/biolreprod61.2.353.
  11. Чернуха Г.Е., Байдукова А.А., Удовиченко М.А., Каприна Е.К., Иванец Т.Ю. Андрогенный профиль пациенток с синдромом поликистозных яичников и его взаимосвязь с метаболической дисфункцией. Акушерство и гинекология. 2019; 11: 122-8
  12. Murray A.A., Gosden R.G., Allison V., Spears N. Effect of androgens on the development of mouse follicles growing in vitro. J. Reprod. Fertil. 1998; 113(1): 27-33. https://dx.doi.org/10.1530/jrf.0.1130027.
  13. Wahlin-Jacobsen S., Pedersen A.T., Kristensen E., Laessoe N.C., Lundqvist M., Cohen A.S. et al. Is there a correlation between androgens and sexual desire in women? J. Sex. Med. 2015; 12(2): 358-73. https://dx.doi.org/10.1111/jsm.12774.
  14. Davis S.R., Davison S.L., Donath S., Bell R.J. Circulating androgen levels and self-reported sexual function in women. JAMA. 2005; 294(1): 91-6. https://dx.doi.org/10.1001/jama.294.1.91.
  15. Позднякова А.А., Шарашкина Н.В., Иванец Т.Ю., Бутарева Л.Б., Рунихина Н.К., Марченко Л.А. Особенности функционального состояния эндотелия и возможности его коррекции при преждевременной недостаточности яичников. Акушерство и гинекология. 2016; 11: 86-94.
  16. Sarrel P.M. Androgen deficiency: menopause and estrogen-related factors. Fertil. Steril. 2002; 77(Suppl. 4): S63-7. https://dx.doi.org/10.1016/s0015-0282(02)02967-9.
  17. Simon J.A. Estrogen replacement therapy: effects on the endogenous androgen milieu. Fertil. Steril. 2002; 77(Suppl. 4): S77-82. https://dx.doi.org/10.1016/s0015-0282(02)02986-2.
  18. Bulun S.E. Physiology and pathology of the female reproductive axis. In: Polonsky K.S., Larsen P.R., Kronenberg H.M., eds. Williams textbook of endocrinology. 12th ed. Philadelphia: Elsevier; 2011: ch.17. https://dx.doi.org/10.1016/B978-1-4377-0324-5.00017-1.
  19. Kotlyar A.M., Seifer D.B. Ethnicity/race and age-specific variations of serum AMH in women - a review. Front. Endocrinol. (Lausanne). 2021; 11: 593216. https://dx.doi.org/10.3389/fendo.2020.593216.
  20. Soman M., Huang L.C., Cai W.H., Xu J.B., Chen J.Y., He R.K. et al. Serum androgen profiles in women with premature ovarian insufficiency: a systematic review and meta-analysis. Menopause. 2019; 26(1): 78-93. https://dx.doi.org/10.1097/GME.0000000000001161.
  21. Nunes-Souza E., Silveira M.E., Mendes M.C., Nagashima S., de Paula C.B.V., Silva G.G.V.C. et al. From adrenarche to aging of adrenal zona reticularis: precocious female adrenopause onset. Endocr. Connect. 2020; 9(12): 1212-20. https://dx.doi.org/10.1530/EC-20-0416.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2021

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies